PPARA and liver cancer: Moreover, it was confirmed that the expression levels of PPARα, PPARγ, FABP1, FABP4, and FABP5 were downregulated in GL22-treated xenograft tumors, which indicates that PPAR-FABPs signaling pathway exerts a significant anticancer effect against liver cancer.